Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132031) titled 'A study on the loss to follow-up rate and influencing factors of intravitreal injection drugs (anti-VEGF drugs) in the real world' on Sept. 9.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Eye Hospital, Wenzhou Medical University

Condition: Age-related macular degeneration

Intervention: Lost to follow-up group:None Not continued follow-up group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-20

Target Sample Size: Lost to follow-up group:150;Not continued follow-up group:50;Continuing follow-up group:600;

Countries of Recruitment:...